Multiple myeloma involves a comprehensive approach that combines blood tests, imaging, and bone marrow studies. Learn about ...

Diagnosis also required -- and still does -- the presence of at least 10% infiltration of clonal plasma cells on bone marrow examination or a biopsy-proven bony or extramedullary plasmacytoma ...

Rapid advances have revolutionized the treatment of multiple myeloma, providing better disease control and prolonging survival. Patients are living years longer, thanks to novel combination therapies ...

--Johnson& Johnson announced today initial Phase 1 results of JNJ-79635322, a novel investigational trispecific antibody in patients with relapsed or refractory multiple myeloma. Findings were ...

Multiple myeloma is a neoplasm that can distort bones, compromising the efficacy of conventional segmentation methodologies during the evaluation of whole body low dose computed tomography. A ...

Multiple myeloma, according to the American Cancer Society, is a type of blood cancer that develops in plasma cells. These cells are normally found in the bone marrow, the soft tissue inside bones ...

They can be performed at your doctor's office or in a hospital clinic.

Detect genomic alterations in tumor cells obtained from either the bone marrow or peripheral blood (circulating tumor cells) of multiple myeloma patients.

Detect genomic alterations in tumor cells obtained from either the bone marrow or peripheral blood (circulating tumor cells) of multiple myeloma patients. Diminish the reliance on FISH and comparable ...

Atamaniuk J, Gleiss A, Porpaczy E, et al. Overexpression of G protein-coupled receptor 5D in the bone marrow is associated with poor prognosis in patients with multiple myeloma.

Background: Multiple myeloma (MM) is a complex hematological malignancy characterized by the clonal expansion of plasma cells in the bone marrow. Emerging studies have emphasized the importance of ...

Alfred L. Garfall, MD, discusses the phase 2 BMT CTN 1902 trial of idecabtagene vicleucel in patients with multiple myeloma.